Suchergebnisse - "Zeidner, Joshua F"

PubPharm (12)

1

Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia

enthalten in: The Journal of clinical investigation | 2022

von Rutella, S. | Vadakekolathu, J. | Mazziotta, F. | +18

CommentIn: Front Immunol. 2023 Oct 31;14:1281687. - PMID 38022588

2

Association of QTc Formula With the Clinical Management of Patients With Cancer

enthalten in: JAMA oncology | 2022

von Richardson, D. | Parish, P. | Tan, X. | +6

CommentIn: JAMA Oncol. 2022 Nov 1;8(11):1566-1568. - PMID 36136318

3

Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia

enthalten in: Transplantation and cellular therapy | 2021

von Tschernia, N. | Kumar, V. | Moore, D. | +10

4

Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS

enthalten in: Leukemia | 2020

von Zeidner, J. | Knaus, H. | Zeidan, A. | +18

5

Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy

enthalten in: JCI insight | 2018

von Knaus, H. | Berglund, S. | Hackl, H. | +9

6

Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML)

enthalten in: Leukemia research | 2018

von Zeidner, J. | Foster, M. | Blackford, A. | +15

7

A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Zeidan, A. | Knaus, H. | Robinson, T. | +17

8

Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML

enthalten in: Blood | 2018

von Swords, R. | Coutre, S. | Maris, M. | +14

CommentIn: Blood. 2018 Mar 29;131(13):1391-1392. - PMID 29599142

9

Phase I Clinical Trials in Acute Myeloid Leukemia : 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute

enthalten in: Journal of the National Cancer Institute | 2016

von Zeidner, J. | Karp, J. | Blackford, A. | +5

10

Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia

enthalten in: Haematologica | 2015

von Zeidner, J. | Foster, M. | Blackford, A. | +15

CommentIn: Haematologica. 2015 Sep;100(9):1105-7. - PMID 26341523